Evidence map›Paper›PMID 33680332›Full record

ReviewJournal of clinical and experimental dentistry2021

Epigenetic alterations in ameloblastomas: A literature review.

Erison-Santana Santos, Carla-Isabelly Rodrigues-Fernandes, Joab-Cabral Cabral, Felipe-Paiva Fonseca, Adriana-Franco-Paes Leme

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of clinical and experimental dentistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Left-sided facial mass in an adult female.Radiology case reports · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Erison-Santana SantosDepartment of Oral Diagnosis, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil.
Carla-Isabelly Rodrigues-FernandesDepartment of Oral Diagnosis, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil.
Joab-Cabral CabralDepartment of Oral Diagnosis, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil.
Felipe-Paiva FonsecaDepartment of Oral Surgery and Pathology, School of Dentistry, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Adriana-Franco-Paes LemeBrazilian Biosciences National Laboratory, The Brazilian Center for Research in Energy and Materials, Campinas, Brazil.
Universidade Estadual de Campinas (UNICAMP) · BRUniversidade Federal de Minas Gerais · BRBrazilian Center for Research in Energy and Materials · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAmeloblastoma is a locally aggressive tumor, originated from odontogenic epithelium, and affects the jawbones with an elevated recurrence rate. The molecular mechanisms involved with the pathogenesis of this tumor remain undetermined. This review aimed to describe the current data regarding epigenetic alterations in ameloblastoma. MATERIAL AND

methodsA systematized electronic search was performed in the English-language literature in three databases, combining the following keywords: ameloblastoma, epigenetic, methylation, noncoding RNA, histone acetylation.

resultsAccording to the gathered results of 11 studies in this review, epigenetic alterations could induce the development and progression of ameloblastoma. DNA methylation has been the most assessed mechanism in ameloblastomas.

conclusionsCurrent literature data indicate that epigenetic events can be involved in the etiopathogenesis of ameloblastomas.

Identifiers

PMID33680332
PMCPMC7920560
OpenAlexW3131798300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.